Annual report [Section 13 and 15(d), not S-K Item 405]

Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit)

v3.25.1
Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
AOCI Attributable to Parent
Accumulated Deficit
Beginning balance at Dec. 31, 2022 $ 91,131 $ 2 $ 455,765 $ (6,908) $ (357,728)
Beginning balance, shares at Dec. 31, 2022   19,467,183      
Exercise of stock options 3   3    
Exercise of stock options, shares   500      
Conversion of warrants to common stock 286   286    
Conversion of warrants to common stock, Share   34,728      
Redemption of fractional shares due to reverse stock split, Shares   (47)      
Redemption of fractional shares due to reverse stock split (1)   (1)    
Net Income (Loss) (77,558)       (77,558)
Foreign currency translation adjustments 2,318     2,318  
Release of Restricted Stock Units, Shares   781,557      
Issuance of common stock under the Equity Distribution Agreement, net (Shares)   2,166,384      
Issuance of common stock under the Equity Distribution Agreement, net 7,866   7,866    
Issuance of common stock upon ESPP purchase, shares   154,371      
Stock compensation expense 12,978   12,978    
Issuance of common stock upon ESPP purchase 727   727    
Net unrealized (loss) gain on investments (net of tax) 34     34  
Ending balance at Dec. 31, 2023 37,784 $ 2 477,624 (4,556) (435,286)
Ending balance, shares at Dec. 31, 2023   22,604,676      
Exercise of stock options $ 335   335    
Exercise of stock options, shares 46,707 46,707      
Net Income (Loss) $ (102,818)       (102,818)
Foreign currency translation adjustments (5,213)     (5,213)  
Release of Restricted Stock Units, Shares   1,444,087      
Issuance of common stock upon ESPP purchase, shares   146,829      
Stock compensation expense 19,449   19,449    
Issuance of common stock under Securities Purchase Agreements, Shares   2,976,191      
Issuance of common stock under Securities Purchase Agreements 37,882 $ 1 37,881    
Issuance of common stock upon ESPP purchase 895   895    
Net unrealized (loss) gain on investments (net of tax) (1)     (1)  
Ending balance at Dec. 31, 2024 $ (11,687) $ 3 $ 536,184 $ (9,770) $ (538,104)
Ending balance, shares at Dec. 31, 2024   27,218,490